Impact of a Biomarker-Based Strategy on Oncology Drug Development: A Meta-analysis of Clinical Trials Leading to FDA Approval.

Impact of a Biomarker-Based Strategy on Oncology Drug Development: A Meta-analysis of Clinical Trials Leading to FDA Approval. J Natl Cancer Inst. 2015 Nov; 107(11).

View in: PubMed

subject areas

Antineoplastic Agents
Biomarkers, Tumor
Clinical Trials as Topic
Drug Approval
Humans
Molecular Targeted Therapy
United States
United States Food and Drug Administration

authors with profiles

Richard Schilsky